New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides

A novel peptide-based pan-influenza A vaccine: A double blind, randomised clinical trial of immunogenicity and safety

(2015) James N. Francis et al.   VACCINE

Viral membrane fusion

(2015) Stephen C. Harrison   VIROLOGY

A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment

(2014) Julia Hoffmann et al.   ANTIVIRAL RESEARCH

Tuning the antimicrobial pharmacophore to enable discovery of short lipopeptides with multiple modes of action

(2014) Yuxin Fang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

A Histidine Residue of the Influenza Virus Hemagglutinin Controls the pH Dependence of the Conformational Change Mediating Membrane Fusion

(2014) C. M. Mair et al.   JOURNAL OF VIROLOGY

New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion

(2013) A. Basu et al.   JOURNAL OF VIROLOGY

Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin

(2013) Jie Yang et al.   Viruses-Basel

H7N9 Incident, immune status, the elderly and a warning of an influenza pandemic

(2013) Yi Guan et al.   Journal of Infection in Developing Countries

Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences

(2012) Nada Ilić et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Design, synthesis and structure–activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion

(2012) Zhibo Zhu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells

(2012) Drirh Khare et al.   EUROPEAN JOURNAL OF NUTRITION

Next generation of antimicrobial peptides as molecular targeted medicines

(2012) Wataru Aoki et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

An Induced Pocket for the Binding of Potent Fusion Inhibitor CL-385319 with H5N1 Influenza Virus Hemagglutinin

(2012) Runming Li et al.   PLoS One

Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010

(2012) Tung Nguyen et al.   VIROLOGY

CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry

(2011) Shuwen Liu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Capturing a Fusion Intermediate of Influenza Hemagglutinin with a Cholesterol-conjugated Peptide, a New Antiviral Strategy for Influenza Virus

(2011) Kelly K. Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin

(2011) Lei Zhu et al.   PLoS One

Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy

(2010) Teruhiko Matsubara et al.   JOURNAL OF MEDICINAL CHEMISTRY

Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation

(2009) Naoki Kawai et al.   JOURNAL OF INFECTION

Structure–activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities

(2008) Ai-Lin Liu et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme

(2008) Judith M. White et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunits

(2008) Qiang Huang et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS